{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:12:05Z","timestamp":1791331925237,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.exphem.2010.03.019","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T07:25:22Z","timestamp":1271057122000},"page":"685-695","source":"Crossref","is-referenced-by-count":18,"title":["A potential activity of valproic acid in the stimulation of interleukin-3\u2212mediated megakaryopoiesis and erythropoiesis"],"prefix":"10.1016","volume":"38","author":[{"given":"Bing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Monma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Masuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Heike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Takaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2010.03.019_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","article-title":"The mammalian epigenome","volume":"128","author":"Bernstein","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2010.03.019_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcp.21678","article-title":"Epigenetic control","volume":"219","author":"Delcuve","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2010.03.019_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2009.03.013","article-title":"Histone deacetylase inhibitors as anti-neoplastic agents","volume":"280","author":"Batty","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2010.03.019_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","article-title":"Prospects: histone deacetylase inhibitors","volume":"96","author":"Dokmanovic","year":"2005","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.exphem.2010.03.019_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/07357900500283119","article-title":"Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents","volume":"23","author":"Garcia-Manero","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.exphem.2010.03.019_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/1535-7163.MCT-07-2284","article-title":"Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics","volume":"7","author":"Hadnagy","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2010.03.019_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ejca.2009.03.001","article-title":"Epigenetic therapies in haematological malignancies: searching for true targets","volume":"45","author":"Altucci","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2010.03.019_bib9","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2010.03.019_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2008.04.008","article-title":"Epigenetics in acute myeloid leukemia","volume":"35","author":"Plass","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib12","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells","volume":"65","author":"Bug","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3324\/haematol.11796","article-title":"Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells","volume":"93","author":"Mahlknecht","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2010.03.019_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2008.01169.x","article-title":"Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions","volume":"82","author":"Seet","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14653240410004899","article-title":"Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal","volume":"6","author":"Young","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.exphem.2010.03.019_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2141.2006.06275.x","article-title":"Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis","volume":"135","author":"Yamamura","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib18","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/sj.onc.1210762","article-title":"Transcriptional control of megakaryocyte development","volume":"26","author":"Goldfarb","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2010.03.019_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(03)00242-5","article-title":"GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte\/erythrocyte lineages","volume":"19","author":"Iwasaki","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2010.03.019_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2008-09-178863","article-title":"A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell- derived primitive hematopoiesis","volume":"114","author":"Klimchenko","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.03.019_bib21","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/sj.onc.1210763","article-title":"Erythroid and megakaryocytic transformation","volume":"26","author":"Wickrema","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2010.03.019_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.exphem.2010.03.019_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.03.019_bib24","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1349-7006.2007.00566.x","article-title":"Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitors","volume":"98","author":"Yamamura","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2010.03.019_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood.V84.4.1085.1085","article-title":"Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis","volume":"84","author":"Mouthon","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.03.019_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V89.5.1471","article-title":"The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors","volume":"89","author":"Bagley","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.03.019_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/stem.160301","article-title":"Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors","volume":"16","author":"Guthridge","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2010.03.019_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/10428199409049629","article-title":"Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers","volume":"13","author":"Nakahata","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2010.03.019_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0301-472X(03)00185-1","article-title":"In vitro expansion of human cord blood CD36+ erythroid progenitors: temporal changes in gene and protein expression","volume":"31","author":"Scicchitano","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0049-3848(03)00142-7","article-title":"Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36","volume":"109","author":"Yang","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/stem.5530110207","article-title":"Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGF beta","volume":"11","author":"Berthier","year":"1993","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2010.03.019_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002770050003","article-title":"Ex vivo expansion of CD34+\/CD41+ late progenitors from enriched peripheral blood CD34+ cells","volume":"79","author":"Halle","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","article-title":"GATA1 in normal and malignant hematopoiesis","volume":"16","author":"Crispino","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.exphem.2010.03.019_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semcdb.2004.11.001","article-title":"Gene expression regulation and domain function of hematopoietic GATA factors","volume":"16","author":"Shimizu","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.exphem.2010.03.019_bib35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2008.17.9812","article-title":"Dysregulation of the C\/EBP Differentiation Pathway in Human Cancer","volume":"27","author":"Koschmieder","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib37","first-page":"743","article-title":"A putative role for histone deacetylase in the differentiation of human erythroid cells","volume":"27","author":"Fujieda","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.V83.2.357.357","article-title":"A phase I\/II study of\u00a0sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes","volume":"83","author":"Nand","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.03.019_bib39","first-page":"875","article-title":"A phase I\/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia","volume":"22","author":"Nimer","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib40","first-page":"1458","article-title":"Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases","volume":"8","author":"Rose","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.03.019_bib41","first-page":"87","article-title":"Interleukin-3 in hematology and oncology: current state of knowledge and future directions","volume":"5","author":"Mangi","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.exphem.2010.03.019_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.seminhematol.2007.04.010","article-title":"Hematopoietic growth factors in the treatment of acquired bone marrow failure states","volume":"44","author":"Marsh","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2010.03.019_bib43","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.2007.15.4906","article-title":"Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome","volume":"26","author":"Jadersten","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2010.03.019_bib44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/cncr.24090","article-title":"An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach","volume":"115","author":"Mundle","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2010.03.019_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02591411","article-title":"Interleukin-3 in the treatment of myelodysplastic syndromes","volume":"22","author":"Ganser","year":"1992","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.leukres.2008.08.014","article-title":"Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms","volume":"33","author":"Hopfer","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2010.03.019_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2010.03.019_bib48","first-page":"1268","article-title":"Measurement of serum cytokine levels in patients with myelodysplastic syndromes","volume":"6","author":"Verhoef","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.03.019_bib49","first-page":"1114","article-title":"Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia","volume":"46","author":"Kanda","year":"2005","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.exphem.2010.03.019_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00043426-199701000-00011","article-title":"Trilineage hematopoietic toxicity associated with valproic acid therapy","volume":"19","author":"Bottom","year":"1997","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T17:22:36Z","timestamp":1591204956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X10001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0301472X10001347"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2010.03.019","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}